Literature DB >> 24948489

Effect of left ventricular diastolic dysfunction on outcomes of atrial fibrillation ablation.

Prabhat Kumar1, Ankit Patel1, J Paul Mounsey1, Eugene H Chung1, Jennifer D Schwartz1, Irion W Pursell1, Anil K Gehi2.   

Abstract

Left ventricular diastolic dysfunction (LVDD) is an important pathogenic factor for atrial fibrillation (AF). There are few data on the effect of LVDD on recurrence of AF after catheter ablation. A cohort of 124 patients (59.9 ± 11.7 years, 73.9% male, and 55% with paroxysmal AF) with recalcitrant AF and normal left ventricular systolic function (left ventricular ejection fraction ≥50%) undergoing ablation was studied. Each patient underwent transthoracic echocardiography, and LVDD was meticulously graded using rhythm-independent (AF or sinus rhythm) transmitral and tissue Doppler parameters. Patients underwent catheter ablation of AF using a stepwise protocol. All patients were followed up at 3, 6, and 12 months with recurrent AF (>30 seconds) captured by electrocardiography and/or 7-day monitor. Kaplan-Meier survival analysis and Cox proportional hazards model were used. There was no LVDD in 72 patients (58%), whereas 33 (26.6%), 10 (8.1%), and 9 (7.3%) patients had grades 1, 2, and 3 LVDD, respectively. AF recurred in 49 patients (39.5%) with median time to recurrence of 248 days. Patients with higher grade of LVDD were increasingly more likely to have recurrence (37.5% for no LVDD and 30.3%, 60%, and 66.7% for grades 1, 2, and 3 LVDD, respectively). Significant LVDD (grade 2 or 3) was an independent predictor of recurrence (hazard ratio 2.6, p = 0.009) after adjusting for persistent (vs paroxysmal) AF and left atrial volume. In conclusion, patients with more severe LVDD have a higher risk of AF recurrence after catheter ablation. These patients may derive less benefit from ablation or may require a more extensive ablation approach.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24948489     DOI: 10.1016/j.amjcard.2014.05.012

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

1.  Impacts of the body size on the left atrial wall thickness and atrial fibrillation recurrence after catheter ablation.

Authors:  Yosuke Nakatani; Tamotsu Sakamoto; Yoshiaki Yamaguchi; Yasushi Tsujino; Naoya Kataoka; Kunihiro Nishida; Koichi Mizumaki; Koichiro Kinugawa
Journal:  Heart Vessels       Date:  2019-02-08       Impact factor: 2.037

2.  Use of acoustic cardiography immediately following electrical cardioversion to predict relapse of atrial fibrillation.

Authors:  Paul Erne; Therese J Resink; Andrea Mueller; Michael Coslovsky; Richard Kobza; David Conen; Peter Bauer; Patricia Arand
Journal:  J Atr Fibrillation       Date:  2017-06-30

3.  "Frailty, thy name is woman": syndrome of women with heart failure with preserved ejection fraction.

Authors:  Dawn M Pedrotty; Mariell Jessup
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2015-02-24

4.  Association of the H2FPEF Risk Score with Recurrence of Atrial Fibrillation Following Pulmonary Vein Isolation.

Authors:  Ravi B Patel; Caitlin Somerville; Fei Fei Gong; Andrew C Peters; Sanjiv J Shah; Alexandru B Chicos; Susan Kim; Bradley P Knight; Albert Lin; Nishant Verma; Rod S Passman
Journal:  J Atr Fibrillation       Date:  2020-04-30

5.  Prognostic significance of diastolic dysfunction in patients with systolic dysfunction undergoing atrial fibrillation ablation.

Authors:  Toshiharu Koike; Koichiro Ejima; Shohei Kataoka; Kyoichiro Yazaki; Satoshi Higuchi; Miwa Kanai; Daigo Yagishita; Morio Shoda; Nobuhisa Hagiwara
Journal:  Int J Cardiol Heart Vasc       Date:  2022-07-04

Review 6.  Who Needs Catheter Ablation And Which Approach?

Authors:  Duygu Kocyigit; Ugur Canpolat; Kudret Aytemir
Journal:  J Atr Fibrillation       Date:  2015-12-31

Review 7.  Evaluating the benefits of home-based management of atrial fibrillation: current perspectives.

Authors:  Azfar B Sheikh; Jamie R Felzer; Abdullah Bin Munir; Daniel P Morin; Carl J Lavie
Journal:  Pragmat Obs Res       Date:  2016-10-13

8.  Troponin I levels in permanent atrial fibrillation-impact of rate control and exercise testing.

Authors:  Anja Wiedswang Horjen; Sara Reinvik Ulimoen; Steve Enger; Jon Norseth; Ingebjørg Seljeflot; Harald Arnesen; Arnljot Tveit
Journal:  BMC Cardiovasc Disord       Date:  2016-05-04       Impact factor: 2.298

Review 9.  Clinical scores for outcomes of rhythm control or arrhythmia progression in patients with atrial fibrillation: a systematic review.

Authors:  Hai Deng; Ying Bai; Alena Shantsila; Laurent Fauchier; Tatjana S Potpara; Gregory Y H Lip
Journal:  Clin Res Cardiol       Date:  2017-05-30       Impact factor: 5.460

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.